Tonix Pharmaceuticals stock halted ahead of FDA approval news
Robert Duchscher, Chief Information Officer of SunOpta Inc (NASDAQ:STKL), a $765 million market cap company, sold 47,500 common shares of the company on August 11, 2025. The sale comes as the stock has shown strong momentum, gaining nearly 14% in the past week according to InvestingPro data. The shares were sold at a weighted average price of $6.2204, for a total value of $295,469. Prices for the sales ranged from $6.0900 to $6.2950. Following the transaction, Duchscher directly owns 11,322 shares of SunOpta Inc (TSX:SOY).
The sale was disclosed in a Form 4 filing with the Securities and Exchange Commission. The filing was signed by Chris McCullough, attorney-in-fact.
In other recent news, SunOpta Inc. conducted its Annual and Special Meeting of Shareholders, where several important proposals were approved. Shareholders voted in favor of electing eight directors to the board, with all nominees receiving a majority of the votes. The newly elected directors are Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, Brian Kocher, David J. Lemmon, Diego Reynoso, Leslie Starr, and Mahes S. Wickramasinghe. Additionally, the meeting included the appointment of an accounting firm and the approval of executive compensation. These developments reflect the company’s ongoing governance activities and shareholder engagement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.